Your browser doesn't support javascript.
loading
Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia.
Seddon, Amanda N; Chaim, Joshua; Akin, Oguz; Drill, Esther; Michael, Angela G; Adel, Nelly; Tallman, Martin S.
Affiliation
  • Seddon AN; Department of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, IL, USA; Department of Pharmacy, Rush University Medical Center, Chicago, IL, USA. Electronic address: aseddo@midwestern.edu.
  • Chaim J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Akin O; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Drill E; Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Michael AG; Department of Pharmacy, Henry Ford Health System, Detroit, MI, USA.
  • Adel N; Department of Pharmacy Practice, Touro College of Pharmacy, New York, NY, USA.
  • Tallman MS; Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Leuk Res ; 68: 48-50, 2018 05.
Article in En | MEDLINE | ID: mdl-29544131

Full text: 1 Database: MEDLINE Main subject: Idarubicin / Leukemia, Myeloid, Acute / Daunorubicin / Typhlitis / Induction Chemotherapy / Antibiotics, Antineoplastic Type of study: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Main subject: Idarubicin / Leukemia, Myeloid, Acute / Daunorubicin / Typhlitis / Induction Chemotherapy / Antibiotics, Antineoplastic Type of study: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2018 Type: Article